US Panel Recommends Pfizer Covid Vaccine For Younger Children
NDTV
The independent experts concluded the known benefits -- both directly to kids' health but also in ending school and other disruptions -- outweighed the known risks.
A medical panel of US government advisors endorsed the Pfizer Covid-19 vaccine in five-to-11-year-olds Tuesday, paving the way for younger children to get their shots within weeks.
The independent experts concluded the known benefits -- both directly to kids' health but also in ending school and other disruptions -- outweighed the known risks.
After a day of presentations and debate, the final vote was 17 in favor and one abstention.
The Food and Drug Administration, which convened the meeting, is expected to give its formal green light soon, making 28 million young Americans eligible for the shot by mid-November.
